Vol. 8 (01) pp. 1078-1084 DOI: 10.21474/IJAR01/10407

CORRELATION OF ANTHRACYCLINE INDUCED EARLY ONSET CHRONIC CARDIO TOXICITY WITH PRO BNP AND ECHOCARDIOGRAPHY

  • Fauji Foundation Hospital Rawalpindi, Pakistan.
16 Downloads 90 Views
Crossref

Article Analytics

References

  1. Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, et al. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. CA Cancer J Clin [Internet] 2016;66(4):309?25. Available from: doi: 10.3322/caac.21341.
  2. Skovgaard D, Hasbak P, Kjaer A. BNP Predicts Chemotherapy-Related Cardiotoxicity and Death : Comparison with Gated Equilibrium Radionuclide Ventriculography. PLoS One [Internet] 2014;9(5):1?10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011788/
  3. Annop KITTIWARAWUT 1, Yongkasem VORASETTAKARNKIJ 2, Suebpong TANASANVIMON 1, Sopark MANASNAYAKORN3 4, And, SRIURANPONG V. Serum NT-proBNP in the early detection of doxorubicin-induced cardiac dysfunction Serum NT-proBNP in the early detection of doxorubicin-induced cardiac dysfunction. Asia Pac J Clin Oncol [Internet] 2013;9(August 2012):155?61. Available from: https://www.researchgate.net/publication/230684416
  4. Rosa GM, Gigli L, Tagliasacchi MI, Di Iorio C, Carbone F, Nencioni A, et al. Update on cardiotoxicity of anti-cancer treatments. Eur. J. Clin. Invest.2016;46(3):264?84.
  5. nosheen fatima. CARDIOTOXICITY OF ANTICANCER DRUGS. Pakistan J Radiol [Internet] 2009;19(1):14?7. Available from: http://www.pakjr.com/ojs/index.php/PJR/article/view/349
  6. Shafi A, Siddiqui N, Imtiaz S, Ud M, Sajid D. LEFT VENTRICULAR SYSTOLIC DYSFUNCTION PREDICTED BY EARLY TROPONIN I RELEASE AFTER ANTHRACYCLINE BASED CHEMOTHERAPY IN BREAST CANCER PATIENTS. J Ayub Med Coll Abbottabad-Pakistan [Internet] 2017;29(2):266?9. Available from: http://jamc.ayubmed.edu.pk/index.php/jamc/article/view/2842
  7. Lewalle A, Land S, Merken JJ, Raafs A, Sep?lveda P, Heymans S, et al. Balance of Active, Passive, and Anatomical Cardiac Properties in Doxorubicin-Induced Heart Failure. Biophys J 2019;1?12.
  8. Cai F, Luis M, Lin X, Wang M, Cai L, Cen C, et al. Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review). Mol Clin Oncol 2019;15?23.
  9. Tian S, Hirshfield KM, Jabbour SK, Toppmeyer D, Haffty BG, Khan AJ, et al. Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients. Front Oncol [Internet] 2014;4(October):1?14. Available from: https://doi.org/10.3389/fonc.2014.00277
  10. Moazeni S, Cadeiras M, Yang EH, Deng MC, Nguyen K-L. Anthracycline induced cardiotoxicity: biomarkers and ?Omics? technology in the era of patient specific care. Clin Transl Med 2017;6(1).
  11. Cardinale D, Sandri MT. Detection and monitoring of cardiotoxicity by using biomarkers: Pros and cons: Remarks on the international colloquium on cardioncology. [Internet]. Prog. Pediatr. Cardiol.2015;39(2):77?84. Available from: http://dx.doi.org/10.1016/j.ppedcard.2015.10.004
  12. Pizzino F, Vizzari G, Bomzer CA, Qamar R, Carerj S, Zito C, et al. Diagnosis of Chemotherapy-Induced Cardiotoxicity. J Patient-Centered Res Rev [Internet] 2014;1(3):121?7. Available from: http://digitalrepository.aurorahealthcare.org/jpcrr/vol1/iss3/3
  13. Tadic M, Cuspidi C. The Role of Echocardiography in Detection of Chemotherapy-Induced Cardiotoxicity in Breast Cancer Patients. Int J Cancer Manag [Internet] 2017;10(5):e8109. Available from: http://ijcancerprevention.com/en/articles/8109.html
  14. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, et al. Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients. Am J Cardiol [Internet] 2011;107(9):1375?80. Available from: https://linkinghub.elsevier.com/retrieve/pii/S000291491100141X
  15. Corremans R, Ad?o R, De Keulenaer GW, Leite-Moreira AF, Br?s-Silva C. Update on pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity. Clin Exp Pharmacol Physiol 2019;46(3):204?15.
  16. Bunney PE, Zink AN, Holm AA, Billington CJ, Kotz CM. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol Behav [Internet] 2017;176(3):139?48. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0031938416312148
  17. Zidan A, Sherief LM, El-Sheikh A, Saleh SH, Shahbah DA, Kamal NM, et al. NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors. Dis Markers 2015;2015.
  18. Wenningmann N, Knapp M, Ande A, Vaidya TR, Ait-Oudhia S. Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring. Mol Pharmacol 2019;96(2):219?32.
  19. Ganame J, Jurcut R, Wildiers H, Ganame J. Detection and monitoring of cardiotoxicity - What does modern cardiology offer ? Detection and monitoring of cardiotoxicity ? what does modern cardiology offer ? Support Cancer Care 2008;16(June):437?45.
  20. Rajadurai J, Tse HF, Wang CH, Yang NI, Zhou J, Sim D. Understanding the Epidemiology of Heart Failure to Improve Management Practices: An Asia-Pacific Perspective. J Card Fail [Internet] 2017;23(4):327?39. Available from: http://dx.doi.org/10.1016/j.cardfail.2017.01.004
  21. Vaidyanathan K, Vasudevan DM. Organ specific tumor markers: What?s new? Indian J Clin Biochem 2012;27(2):110?20.
  22. Tan LL, Lyon AR. Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment. Curr Treat Options Cardiovasc Med 2018;20(7).
  23. Bando S, Soeki T, Matsuura T, Tobiume T, Ise T, Kusunose K, et al. Plasma brain natriuretic peptide levels are elevated in patients with cancer. PLoS One 2017;12(6):1?15.

How to Cite This Article

Asif Riaz Khan, Fauzia Abdus Samad, Abdus Samad, Sharmin Arif and Anum Khan (2020); CORRELATION OF ANTHRACYCLINE INDUCED EARLY ONSET CHRONIC CARDIO TOXICITY WITH PRO BNP AND ECHOCARDIOGRAPHY, Int. J. of Adv. Res., 8 (01), 1078-1084, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/10407

Corresponding Author

Dr. Asif Riaz Khan
Fauji Foundation Hospital Rawalpindi, Pakistan